Have you just been diagnosed with Type 1 Diabetes?
This study aims to determine the safety and feasibility of a tablet called empagliflozin to treat type 1 diabetes soon after it is diagnosed.
Anticipated date enrolment will close: June 2018
Who can take part
Diagnosed with type 1 diabetes within the last 100 days
Age between 18 and 40
What is involved for you
- 13 visits over 9 months
- 4 pancreas function tests wherein blood samples are collected before and after a liquid meal
- 4 periods wherein a continuous glucose monitor is worn for 5 days